Related Experiment Video

Updated: Jul 9, 2026

Building Up Skin Models for Numerous Applications - from Two-Dimensional (2D) Monoculture to Three-Dimensional (3D) Multiculture
08:32

Building Up Skin Models for Numerous Applications - from Two-Dimensional (2D) Monoculture to Three-Dimensional (3D) Multiculture

Published on: October 20, 2023

Endogenous growth factors as cosmeceuticals

Rahul C Mehta1, Richard E Fitzpatrick

  • 1Research and Development, SkinMedica, Inc., Carlsbad, California, USA.

Dermatologic Therapy
|November 30, 2007
PubMed

Insights

Human growth factors applied topically can reverse skin aging signs like wrinkles. Clinical studies show they reduce fine lines and boost collagen, but more research is needed to confirm effects and ensure product quality.

Area of Science:

  • Dermatology and aging research.
  • Biochemistry of skin aging.
  • Regenerative medicine applications.

Background:

  • Skin aging results from chronological and environmental factors, including oxidative stress.
  • Oxidation degrades collagen and elastin, leading to facial aging.
  • Growth factors are crucial in cellular processes and tissue repair.

Purpose of the Study:

  • To evaluate the efficacy of topical human growth factors in reversing skin aging.
  • To assess the impact of growth factors on collagen synthesis and visible aging signs.
  • To identify areas for further research and quality control in growth factor products.

Main Methods:

  • Review of multiple clinical studies on topical human growth factor application.
  • Analysis of data on reduction in fine lines and wrinkles.
  • Assessment of changes in dermal collagen synthesis.

Main Results:

  • Topical human growth factors demonstrated a statistically significant reduction in fine lines and wrinkles.
  • Increased dermal collagen synthesis was observed with growth factor treatment.
  • Preliminary clinical evidence supports the anti-aging effects of growth factors.

Conclusions:

  • Topical human growth factors show promise in mitigating skin aging.
  • Further double-blind, controlled studies are necessary to validate these findings.
  • Establishing robust quality and stability controls for growth factor products is essential.

More Related Videos

3D Analysis of Multi-cellular Responses to Chemoattractant Gradients05:57

3D Analysis of Multi-cellular Responses to Chemoattractant Gradients

Published on: May 24, 2019

Generation of hiPSC-Derived Intestinal Organoids for Developmental and Disease Modelling Applications06:34

Generation of hiPSC-Derived Intestinal Organoids for Developmental and Disease Modelling Applications

Published on: March 8, 2024

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...